Such findings of the strong association of MAL overexpression, along with radiology imaging features from ImaGene, highlight the strength of ImaGene to conduct noninvasive radiogenomic studies in HNSCC. The gene discussed is MAL; the disease is head and neck squamous cell carcinoma.